Nerea Moreno-Herraiz

Ms. Nerea Moreno-Herraiz

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IOIris Otero-Luis
Iris Otero-Luis
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
CÁCelia Álvarez-Bueno
Celia Álvarez-Bueno
AMArturo Martinez-Rodrigo
Arturo Martinez-Rodrigo
CPCarlos Pascual-Morena
Carlos Pascual-Morena
ASAlicia Saz-Lara
Alicia Saz-Lara
Background: Spasticity is a motor disorder characterised by exaggerated movements of the tendons and accompanied by hyperreflexia and hypertonia. Extracorporeal shock wave therapy (ESWT) is used as a treatment for spasticity, although more evidence is needed on the effectiveness of this therapy in the treatment of spasticity. Therefore, the aim of this study was to assess the effectiveness ESWT in the treatment of upper and lower limbs spasticity in both children and adults through different aetiologies. Methods: A systematic search was performed in different databases from inception to December 2023. Random-effects meta-analysis was used to estimate the efficacy of ESWT on spasticity using the Modified Ashworth Scale. Results: Sixteen studies were included in the systematic review and meta-analysis. The effect of ESWT on spasticity measured with the Modified Ashworth Scale shows a significant decrease in spasticity in the upper limbs and in the lower limbs in adults with chronic stroke and in children with cerebral palsy, is more effective immediately after application, and maintains its effect up to 12 weeks post treatment. Conclusions: These findings are important for clinical practice since they show evidence that ESWT is effective in reducing spasticity in both children and adults.

11 March 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
CPCarlos Pascual-Morena
Carlos Pascual-Morena
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
Irene Martínez GarcíaIrene Martínez García
Irene Martínez García
EGEva Rodríguez Gutiérrez
Eva Rodríguez Gutiérrez
MLMaría Isabel Lucerón-Lucas-Torres
María Isabel Lucerón-Lucas-Torres
ASAlicia Saz-Lara
Alicia Saz-Lara
Previous evidence associates insulin resistance with arterial stiffness in various pathologies, yet limited reports exist in healthy adults. Therefore, this study aims to estimate the association between insulin resistance and arterial stiffness in healthy adults. The cross-sectional EVasCu study enrolled 390 participants (42.05 ± 13.15 years). ANCOVAs, unadjusted (model 1) and adjusted (model 2), explored the association between arterial stiffness markers (aortic Pulse Wave Velocity [aPWV], Augmentation Index [AIx@75] and Cardio-Ankle Vascular Index [CAVI]), and insulin resistance markers (Homeostasis Model Assessment of Insulin Resistance [HOMA-IR], Quantitative Insulin Sensitivity Check Index [QUICKI] and Triglycerides-Glucose [TyG]). In model 1, all insulin resistance markers were associated with aPWV, HOMA-IR and QUICKI were associated with AIx@75, and the TyG index was associated with CAVI. In model 2, HOMA-IR and QUICKI increased aPWV by 0.179 and 0.156 m/s (p = 0.001 and p = 0.011), and AIx@75 by 4.17 and 5.39% (p = 0.009 and p = 0.003). The EVasCu study offers valuable insights into the relationship between insulin resistance and arterial stiffness in healthy adults, providing a deeper understanding of metabolic and cardiovascular health. By examining this influence, we embark on an intriguing exploration of how these factors interplay in the human body.

28 February 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
IOIris Otero-Luis
Iris Otero-Luis
AMArturo Martinez-Rodrigo
Arturo Martinez-Rodrigo
ICIván Cavero-Redondo
Iván Cavero-Redondo
NMNerea Moreno-Herraiz
Nerea Moreno-Herraiz
Irene Martínez GarcíaIrene Martínez García
Irene Martínez García
ASAlicia Saz-Lara
Alicia Saz-Lara
Background: Spasticity is a very common neurological sequelae that significantly impacts the quality of life of patients, affecting more than 12 million people worldwide. Botulinum toxin is considered a reversible treatment for spasticity, but due to the large amount of available evidence, synthesis seems necessary. Therefore, we conducted an overview of existing systematic reviews and meta-analyses to evaluate the effect of botulinum toxin injections in the treatment of spasticity of different etiologies. Methods: A systematic search of different databases, including Pubmed, Scopus, the Cochrane Library, and Web of Science, was performed from inception to February 2024. Standardized mean differences (SMDs) and their respective 95% confidence intervals (CIs) were calculated to assess the effect of botulinum toxin compared to that of the control treatment using the Modified Ashworth Scale (MAS). All the statistical analyses were performed using STATA 15 software. Results: 28 studies were included in the umbrella review. The effect of botulinum toxin injections on spasticity, as measured by the MAS, was significantly lower in all but three studies, although these studies also supported the intervention. The SMDs reported by the meta-analyses ranged from −0.98 to −0.01. Conclusion: Botulinum toxin injections were effective at treating spasticity of different etiologies, as indicated by the measurements on the MAS. This implies an improvement in muscle tone and, consequently, in the patient’s mobility and quality of life.

25 November 2024 in Journal of Medical Internet Research
Verified
Journal Article
Open access
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
AMArturo Martinez-Rodrigo
Arturo Martinez-Rodrigo
ASAlicia Saz-Lara
Alicia Saz-Lara
NMNerea Moreno-Herraiz
Nerea Moreno-Herraiz
VCVeronica Casado-Vicente
Veronica Casado-Vicente
RGRIGIPREV Investigators Group
RIGIPREV Investigators Group
Background: High systolic blood pressure is one of the leading global risk factors for mortality, contributing significantly to cardiovascular diseases. Despite advances in treatment, a large proportion of patients with hypertension do not achieve optimal blood pressure control. Arterial stiffness (AS), measured by pulse wave velocity (PWV), is an independent predictor of cardiovascular events and overall mortality. Various antihypertensive drugs exhibit differential effects on PWV, but the extent to which these effects vary depending on individual patient characteristics is not well understood. Given the complexity of selecting the most appropriate antihypertensive medication for reducing PWV, machine learning (ML) techniques offer an opportunity to improve personalized treatment recommendations. Objective: This study aims to develop an ML model that provides personalized recommendations for antihypertensive medications aimed at reducing PWV. The model considers individual patient characteristics, such as demographic factors, clinical data, and cardiovascular measurements, to identify the most suitable antihypertensive agent for improving AS. Methods: This study, known as the RIGIPREV study, used data from the EVA, LOD-DIABETES, and EVIDENT studies involving individuals with hypertension with baseline and follow-up measurements. Antihypertensive drugs were grouped into classes such as angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, diuretics, and combinations of diuretics with ACEIs or ARBs. The primary outcomes were carotid-femoral and brachial-ankle PWV, while the secondary outcomes included various cardiovascular, anthropometric, and biochemical parameters. A multioutput regressor using 6 random forest models was used to predict the impact of each antihypertensive class on PWV reduction. Model performance was evaluated using the coefficient of determination (R2) and mean squared error. Results: The random forest models exhibited strong predictive capabilities, with internal validation yielding R2 values between 0.61 and 0.74, while external validation showed a range of 0.26 to 0.46. The mean squared values ranged from 0.08 to 0.22 for internal validation and from 0.29 to 0.45 for external validation. Variable importance analysis revealed that glycated hemoglobin and weight were the most critical predictors for ACEIs, while carotid-femoral PWV and total cholesterol were key variables for ARBs. The decision tree model achieved an accuracy of 84.02% in identifying the most suitable antihypertensive drug based on individual patient characteristics. Furthermore, the system’s recommendations for ARBs matched 55.3% of patients’ original prescriptions. Conclusions: This study demonstrates the utility of ML techniques in providing personalized treatment recommendations for antihypertensive therapy. By accounting for individual patient characteristics, the model improves the selection of drugs that control blood pressure and reduce AS. These findings could significantly aid clinicians in optimizing hypertension management and reducing cardiovascular risk. However, further studies with larger and more diverse populations are necessary to validate these results and extend the model’s applicability.

6 July 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
IOIris Otero-Luis
Iris Otero-Luis
ASAlicia Saz-Lara
Alicia Saz-Lara
NMNerea Moreno-Herraiz
Nerea Moreno-Herraiz
CLCarla Geovanna Lever-Megina
Carla Geovanna Lever-Megina
BPBruno Bizzozero Peroni
Bruno Bizzozero Peroni
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
(1) Background: Previous evidence has indicated a connection between a Mediterranean diet and cardiovascular disease. However, evidence for subclinical markers of cardiovascular disease, such as arterial stiffness, is limited. Therefore, the aim of this study was to assess the associations between adherence to the Mediterranean diet (MD), as assessed by the MEDAS-14 questionnaire, and arterial stiffness, as assessed by aortic pulse wave velocity, in healthy adults and according to sex. (2) A cross-sectional study including 386 healthy participants was performed in the EVasCu study. Adjusted and unadjusted differences in adherence to the MD and arterial stiffness were determined using Student’s t test and ANCOVA for the total sample and according to sex. (3) Results: Our results showed that individuals with a high adherence to the MD had a greater arterial stiffness, both in the total sample and in females, although this difference was not significant after adjusting for possible confounding variables, such as age. (4) Conclusions: Our findings indicated that, in the unadjusted analyses, healthy subjects with a high adherence to the MD showed a greater arterial stiffness. When these analyses were adjusted, no significant differences were shown in a-PWv according to the categories of MD adherence.

28 October 2024 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
ASAlicia Saz-Lara
Alicia Saz-Lara
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
NMNerea Moreno-Herraiz
Nerea Moreno-Herraiz
ERElena Rescalvo-Fernández
Elena Rescalvo-Fernández
CBCarlos Berlanga-Macías
Carlos Berlanga-Macías
CPCarlos Pascual-Morena
Carlos Pascual-Morena